Sam Altman: o3-mini with Day-One API Confirmed Coming Soon, Plus o3 pro Priced at $200 and Hinted as Extraordinary!

Royal Bank of Canada restated their outperform rating on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) in a report released on Wednesday morning,Benzinga reports. The firm currently has ...

Vanguard to pay $106.41M penalty for misleading investors on capital gains distributions and tax consequences in target date ...

Wall Street is suddenly uneasy about Trump's agenda, and the markets are sending him a message ...

Fintel reports that on January 16, 2025, UBS downgraded their outlook for Regeneron Pharmaceuticals (NasdaqGS:REGN) from Buy ...

VFMO offers investors diversified exposure to small, mid & large-cap stocks with strong short- and long-term momentum ...

Drug maker Johnson & Johnson is exploring a bid to acquire Intra-Cellular Therapies , a biopharmaceutical company, Bloomberg ...

Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by equities ...